3 Stocks With Upside Potential: Profire Energy, Inc. (PFIE), JAKKS Pacific, Inc. (JAKK) and Signal Genetics Inc (SGNL)
New York, NY – GDP INSIDER – 03/25/2015.
This article discusses three companies: Profire Energy, Inc. (NASDAQ:PFIE), JAKKS Pacific, Inc. (NASDAQ:JAKK) and Signal Genetics Inc (NASDAQ:SGNL)
Profire Energy, Inc. (NASDAQ:PFIE) gained ten cents to end yesterday’s trading session at $1.39, a 7.75% increase in value from its previous closing price on higher than normal trading volume of 1.43 million compared to its 30-day average trading volume of 0.181 million. However, the day could have been worse for the company as the stock traded for as little as $1.22 during the day, a new 52 week low for Lindon-based combustion management technologies developer. Profire Energy, Inc has been declining so far this year with the stock down 39.04% YTD compared to the S&P 500 which is up 1.58% for the same period. With RSI of 25.17, the stock may be undervalued, but with the oil industry in decline it is better to hold than buy at this time.
JAKKS Pacific, Inc. (NASDAQ:JAKK) reversed its recent downward trend yesterday to close up 0.30% or $0.02 at $6.71 with more than 1.53 million shares changing hands, compared to its 30 day average trading volume of 0.546 million. The California-based multi brand toy company has been in steady decline for the last one year with the stock down 6.42%, compared to the S&P 500 which is up 12.11% for the same period. The RSI of 57.30 indicates the stock is not overvalued at the current levels, the MFI of 32.31 shows that money is flowing in the right direction and still has room to improve. With quarterly revenue growth (yoy) of 84.50% and quarterly earnings growth (yoy) of 130.10%, JAKKS Pacific, Inc looks well positioned for further gains making it a hold with a view to buy.
Signal Genetics Inc (NASDAQ:SGNL) surged $0.63 to end yesterday’s trading session at $2.85, a 28.55% increase in value from its previous closing price of $2.21 on high trading volume of 1.40 million compared to its three month average trading volume of 0.487 million. Despite the gain, the commercial stage molecular diagnostic company remains well below its 52 week high of $9.99. Over the past one week and over the past four weeks, the shares of Signal Genetics Inc have gained 16.12% and 4.21%, respectively. With RSI of 55.37 and one year price target estimate of $12, the stock has more upside potential making it a hold with a view to buy.
UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.
UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Disclosure: UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.